Antidepressant-like effect of Ikwitang involves modulation of monoaminergic systems

Kim,Hee‑Yun; Jeong,Hyun‑Ja; Kim,Hyung‑Min

doi:10.3892/mmr.2016.4809

Antidepressant-like effect of Ikwitang involves modulation of monoaminergic systems

Authors:
- Hee‑Yun Kim
- Hyun‑Ja Jeong
- Hyung‑Min Kim
View Affiliations

Affiliations: Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 130‑701, Republic of Korea, Department of Food Technology, Inflammatory Disease Research Center, Hoseo University, Asan, Chungnam 336‑795, Republic of Korea
Published online on: January 27, 2016 https://doi.org/10.3892/mmr.2016.4809
Pages: 2815-2820

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Depression is a chronic mental disorder. Inflammatory reactions have an important function in the pathophysiology of depression. Ikwitang (IW) has been used to treat fever and inflammatory diseases, however, its effect on depression has not been previously investigated. Therefore, the present study evaluated the possible antidepressant‑like effect of IW using a forced swimming test (FST) in mice. IW was orally administered for 14 days. On the 14 day, IW was administered 1 h prior to the FST. The immobility durations of the IW groups (0.01, 0.1 and 1 g/kg) were significantly decreased, compared with those of the distilled water (D.W.) groups. The reduction of immobility duration by IW was associated with significant increases in the levels of serotonin, noradrenaline and estrogen receptor‑β in the brain. IW significantly increased the levels of brain‑derived neurotrophic factor and phosphorylated extracellular signal‑regulated kinases, compared with the D.W. groups. In addition, the levels of inflammatory cytokines were significantly reduced following IW administration in the hippocampus and serum. In conclusion, the results of the present study suggested that the antidepressant effect of IW may be associated with the modulation of monoaminergic systems and inflammatory reactions.

View Figures

View References

1	Alfonso J, Frasch AC and Flugge G: Chronic stress, depression and antidepressants: Effects on gene transcription in the hippocampus. Rev Neurosci. 16:43–56. 2005. View Article : Google Scholar : PubMed/NCBI
2	Reeves RR and Ladner ME: Antidepressant-induced suicidality: An update. CNS Neurosci Ther. 16:227–234. 2010.PubMed/NCBI
3	Shively CA, Mirkes SJ, Lu NZ, Henderson JA and Bethea CL: Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J. 3:114–121. 2003. View Article : Google Scholar : PubMed/NCBI
4	Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH and Li XJ: Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav. 82:200–206. 2005. View Article : Google Scholar : PubMed/NCBI
5	Lee S, Jeong J, Kwak Y and Park SK: Depression research: Where are we now? Mol Brain. 3:82010. View Article : Google Scholar : PubMed/NCBI
6	Ji XW, Wu CL, Wang XC, Liu J, Bi JZ and Wang DY: Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression. Exp Ther Med. 8:159–164. 2014.PubMed/NCBI
7	Watanabe K, Hashimoto E, Ukai W, Ishii T, Yoshinaga T, Ono T, Tateno M, Watanabe I, Shirasaka T, Saito S and Saito T: Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats. Prog Neuropsychopharmacol Biol Psychiatry. 34:1450–1454. 2010. View Article : Google Scholar : PubMed/NCBI
8	Patterson M and Yasuda R: Signalling pathways underlying structural plasticity of dendritic spines. Braz J Pharmacol. 163:1626–1638. 2011. View Article : Google Scholar
9	Maes M: Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 19:11–38. 1995. View Article : Google Scholar : PubMed/NCBI
10	Go JH, Jung JH, Chang YJ, Kim HM and Chung YJ: Ikwi-tang for the treatment of allergic rhinitis as a traditional medicine. TANG. 3:37–42. 2013.
11	Lee YC, Lee JC, Seo YB and Kook YB: Liriopis tuber inhibit OVA-induced airway inflammation and bronchial hyperresponsiveness in murine model of asthma. J Ethnopharmacol. 101:144–152. 2005. View Article : Google Scholar : PubMed/NCBI
12	Kang M, Shin D, Oh JW, Cho C, Lee HJ, Yoon DW, Lee SM, Yun JH, Choi H, Park S, et al: The anti-depressant effect of Nelumbinis semen on rats under chronic mild stress induced depression-like symptoms. Am J Chin Med. 33:205–213. 2005. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Roh SS, Kim SH, Lee YC and Seo YB: Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia and bronchial hyperresponsiveness. Mediators Inflamm. 2008:7814252008. View Article : Google Scholar
15	Masi G and Brovedani P: The hippocampus, neurotrophic factors and depression: Possible implications for the pharmacotherapy of depression. CNS Drugs. 25:913–931. 2011. View Article : Google Scholar : PubMed/NCBI
16	Walf AA, Koonce CJ and Frye CA: Adult female wildtype, but not oestrogen receptor beta knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile. J Psychopharmacol. 23:442–450. 2009. View Article : Google Scholar
17	Schmidt HD and Duman RS: The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol. 18:391–418. 2007. View Article : Google Scholar : PubMed/NCBI
18	Gerrits M, Westenbroek C, Koch T, Grootkarzijn A and ter Horst GJ: Increased lim-bic phosphorylated extra-cellular-regulated kinase 1 and 2 expression after chronic stress is reduced by cyclic 17beta-estradiol administration. Neuroscience. 142:1293–1302. 2006. View Article : Google Scholar : PubMed/NCBI
19	Jeong HJ, Kim JH, Kim NR, Yoou MS, Nam SY, Kim KY, Choi Y, Jang JB, Kang IC, Baek NI and Kim HM: Antidepressant effect of Stillen. Arch Pharm Res. 38:1223–1231. 2015. View Article : Google Scholar
20	Hughes ZA, Liu F, Platt BJ, Dwyer JM, Pulicicchio CM, Zhang G, Schechter LE, Rosenzweig-Lipson S and Day M: WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology. 54:1136–1142. 2008. View Article : Google Scholar : PubMed/NCBI
21	Petit-Demouliere B, Chenu F and Bourin M: Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology (Berl). 177:245–255. 2005. View Article : Google Scholar
22	Zheng M, Fan Y, Shi D and Liu C: Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system. J Ethnopharmacol. 147:108–113. 2013. View Article : Google Scholar : PubMed/NCBI
23	Delgado PL: Depression: The case for a monoamine deficiency. J C Psychiatry. 61(Suppl 6): S7–S11. 2000.
24	Kumar N, Dhayabaran D, Nampoothiri M, Nandakumar K, Puratchikody A, Lalani N, Dawood K and Ghosh A: Atypical antidepressant activity of 3,4-Bis(3,4-Dimethoxyphenyl) Furan-2,5-Dione Isolated from heart wood of cedrus deodara, in rodents. Korean J Physiol Pharmacol. 18:365–369. 2014. View Article : Google Scholar : PubMed/NCBI
25	Shughrue PJ, Lane MV and Merchenthaler I: Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol. 388:507–525. 1997. View Article : Google Scholar : PubMed/NCBI
26	Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP and Hickey GJ: 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl). 179:637–643. 2005. View Article : Google Scholar
27	Imwalle DB, Gustafsson JA and Rissman EF: Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav. 84:157–163. 2005. View Article : Google Scholar : PubMed/NCBI
28	Binder DK and Scharfman HE: Brain-derived neurotrophic factor. Growth Factors. 22:123–131. 2004. View Article : Google Scholar : PubMed/NCBI
29	Lee BH and Kim YK: The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investing. 7:231–235. 2010. View Article : Google Scholar
30	Heldt SA, Stanek L, Chhatwal JP and Ressler KJ: Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry. 12:656–670. 2007. View Article : Google Scholar : PubMed/NCBI
31	Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK and p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
32	Zhang X, Jin C, Li Y, Guan S, Han F and Zhang S: Catalpol improves cholinergic function and reduces inflammatory cytokines in the senescent mice induced by D-galactose. Food Chem Toxicol. 58:50–55. 2013. View Article : Google Scholar : PubMed/NCBI
33	Capuron L and Miller AH: Immune system to brain signaling: Neuropsychopharmacological implications. Pharmacol Ther. 130:226–238. 2011. View Article : Google Scholar : PubMed/NCBI
34	Chen W, Li X, Jia LQ, Wang J, Zhang L, Hou D, Wang J and Ren L: Neuroprotective activities of catalpol against CaMKII-dependent apoptosis induced by LPS in PC12 cells. Br J Pharmacol. 169:1140–1152. 2013. View Article : Google Scholar : PubMed/NCBI